Document:

<PAGE>   1
                                                                  EXHIBIT 10.182

                             STOCK OPTION AGREEMENT

               STOCK OPTION AGREEMENT (the "Agreement"), dated as of September
18, 2000 between Wilshire Technologies, Inc., a California corporation (referred
to herein as "Grantor" or "Company"), and E. I. du Pont de Nemours and Company,
a Delaware corporation (referred to herein as the "Grantee" or "DuPont").

               WHEREAS, the Grantor and Grantee are entering into a Product
Development, Purchase and License Agreement, dated as of the date hereof (the
"PDP&L Agreement"), which provides among other things, for the development of
polyurethane material to be utilized in the manufacture of gloves in certain
end-markets, and

               WHEREAS, the Grantor as an inducement to Grantee to enter the
PD&D Agreement wishes to grant to the Grantee an option to purchase up to
2,000,000 shares of its common stock, no par value , of the Grantor (the "Common
Stock"), and certain other rights on the terms and subject to the conditions set
forth herein.

               NOW, THEREFORE, in consideration of the premises and the mutual
covenants and agreements set forth herein, the parties hereto, intending to be
legally bound hereby, agree as follows:

               1. Definitions. The following terms shall have the meanings set
forth below:

                      (a) "Commission" means the Securities and Exchange
Commission, or any other Federal agency at the time administering the Federal
securities laws.

                      (b) "Company Material Adverse Effect" means any change in
or effect on the business of the Company and its Subsidiaries that is, or is
reasonably likely to be materially adverse to the business, operations or assets
(including intangible assets), prospects, or financial condition of the Company
and its Subsidiaries, taken as a whole.

                      (c) "Securities Act" means the Securities Act of 1933, as
amended, or any similar Federal statute, and the rules and regulations of the
Commission issued under such Act, as they each may, from time to time, be in
effect.

                      (d) "Exchange Act" means the Securities Exchange Act of
1934 or any similar Federal statute, and the rules and regulations of the
Commission issued under such Act, as they each may, from time to time, be in
effect.

                      (e) "Person" shall have the meaning specified in Sections
3(a)(9) and 13(d)(3) of the Exchange Act. Notwithstanding any other provision of
this

<PAGE>   2

Agreement, any reference to a majority of the total issued and outstanding
shares or Shares on a fully diluted basis, or similar references, shall, for
purposes of this Agreement, exclude from the determination thereof any shares of
Common Stock issuable upon exercise of or subject to this Agreement and any
reference to beneficial ownership of shares of Common Stock or similar
references shall, for purposes of this Agreement, exclude from the determination
thereof any shares of Common Stock issuable upon exercise of or subject to this
Agreement.

                      (f) "Registrable Shares" means all of the shares, and any
other shares of Common Stock or other securities of the Company or any other
issuer issued or issuable in respect of such shares (because of stock splits,
stock dividends, reclassifications, recapitalizations, mergers, combinations or
similar events, if applicable) acquired by DuPont pursuant to the terms of the
Option granted in Section 2 herein; provided, however, that the shares which are
Registrable Shares shall cease to be Registrable Shares upon any sale or
transfer of such shares pursuant to a Registration Statement, Section 4(1) of
the Securities Act, Rule 144 under the Securities Act or otherwise, except that
the shares which are Registrable Shares shall remain Registrable Shares in the
event of a transfer of the total number of shares owned by DuPont to any third
party, which includes its Subsidiaries or affiliates (a "DuPont Transferee"). As
a condition to effecting any registration pursuant to this Agreement, the
Company may require that DuPont, or any DuPont Transferee, on whose behalf a
registration hereunder is being effected, execute an agreement further
acknowledging their obligations under Section 17 of this Agreement. All
references in this Agreement to DuPont shall be read to include any DuPont
Transferee that owns or holds any Registrable Shares.

                      (g) "Registration Expenses" means the expenses described
in Section 14.

                      (h) "Registration Statement" means a registration
statement filed by the Company with the Commission for a public offering and
sale of securities of the Company (other than any registration statement on Form
S-4 or Form S-8, or their successors, or any other form for a limited purpose,
or any registration statement covering only securities proposed to be issued in
exchange for securities or assets of another corporation or entity or as merger
consideration).

                      (i) "Subsidiary" means, any entity, whether incorporated
or unincorporated, of which at least fifty percent (50%) of the securities or
ownership interests having by their terms ordinary voting power to elect fifty
percent (50%) of the board of directors or other persons performing similar
functions is directly or indirectly owned or controlled by such party or by one
or more of its respective Subsidiaries or by such party and any one or more of
its respective Subsidiaries.

               2.     The Option; Exercise; Adjustments; Payment of Spread.

<PAGE>   3

                      (a) Subject to the other terms and conditions set forth
herein, in consideration of and as an inducement to Grantee to enter the PDP&L
Agreement, Grantor hereby grants to the Grantee an irrevocable option (the
"Option") to acquire a minimum of 500,000 shares of Common Stock (the "Option
Shares") up to a maximum of 2,000,000 Option Shares at a cash purchase price
equal to $.50 per share (the "Purchase Price"), or as an alternative, Grantee
may elect to reduce the number of shares that are subject to the Option and
return these shares to the Grantor (the "Returned Option Shares") to the extent
that the value of the Returned Option Shares (Market Value less Purchase Price
of Returned Option Shares) equals the Purchase Price PROVIDED that Market Value
shall equal the lowest trading price for Common Stock recorded for the ten
trading days preceding the date of Grantee's Stock Option Notice .

                      (b) The Option may be exercised by the Grantee, in whole
or in part, at any time, but only on one occasion prior to December 31, 2003
(the "Termination"). Any portion of the Option that remains unexercised as of
11:59 p.m., Eastern Standard Time on December 31, 2003 shall terminate on such
date.

                      (c) In the event Grantee wishes to exercise the Option,
Grantee shall send a written notice to the Grantor (the "Stock Exercise Notice")
specifying the total number of shares it wishes to purchase and a date (subject
to the expiration or termination of any applicable waiting period under the HSR
Act (as defined below)) not later than 15 business days and not earlier than 3
business days following the date such notice is given for the closing of such
purchase. In the event of any change in the number of issued and outstanding
shares of capital stock of the Grantor by reason of any stock dividend, stock
split, recapitalization or merger, the number of shares subject to this Option
and the purchase price per share shall be appropriately adjusted to restore the
Grantee to its rights hereunder.

               3.     Approvals and Consents; Cooperation.

                      (a) The Company and Grantee shall cooperate with each
other and use (and shall cause their respective Subsidiaries to use) their
respective commercially reasonable best efforts to take or cause to be taken all
actions, and do or cause to be done all things, necessary, proper or advisable
under this Agreement and applicable Laws to consummate and make effective the
transactions contemplated by this Agreement as soon as practicable, including
preparing and filing as promptly as practicable all documentation to effect all
necessary applications, notices, petitions, filings and other documents and to
obtain as promptly as practicable all permits, consents, approvals and
authorizations necessary or advisable to be obtained from any third party and/or
any Governmental Entity (as defined in Section 10(f)) in order to consummate the
Sale or any of the other transactions contemplated by this Agreement.

                      (b) In particular, the Company and Grantee each agree to
use commercially reasonable efforts to take, or cause to be taken, all
appropriate action, and do, or cause to be done, such things as may be necessary
under federal or state securities laws or the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the HSR

<PAGE>   4

Act) applicable to or necessary for, and will file as soon as reasonably
practicable and, if appropriate, the Company use commercially reasonable efforts
to have declared effective or approved, all documents and notifications with the
Commission and other governmental or regulatory bodies that it deems necessary
or appropriate for, the consummation of the transactions contemplated hereby and
each party shall give the other information reasonably requested by such other
party pertaining to it to enable such other party to take such actions.

               4. Commission Filings; De-registration. The Company shall use its
best efforts to make all required filings under the Exchange Act in a timely
manner. The Company shall use its best efforts to prevent its Common Stock from
being de-registered under the Exchange Act, or from any national securities
exchange or system, if the Company's Common Stock is registered or listed on an
exchange or system during the term of this Agreement.

               5. Publicity. Any press release relating to the Sale or this
Agreement shall be made available to Grantee to afford Grantee a reasonable time
to review and comment on the proposed release. Notwithstanding the previous
sentence, the Company shall have the right to make the final determination of
the content of such release.

               6. Expenses. All costs and expenses incurred in connection with
this Agreement and the transactions contemplated herein shall be paid by the
party incurring such expense.

               7. Conditions to Delivery of Shares. The Grantor's obligation to
deliver Option Shares upon exercise of the Option is subject only to the
conditions that:

                      (a) No preliminary or permanent injunction or other order
issued by any federal or state court of competent jurisdiction prohibiting the
delivery of the Option Shares shall be in effect; and

                      (b) Any applicable waiting periods under the HSR Act shall
have expired or been terminated; and

                      (c) The representations and warranties of the Grantor and
Grantee made in Sections 10 and 11, respectively, of this Agreement shall be
true and correct in all material respects as of the date of the closing of the
issuance of the Option Shares or Grantor has provided Grantee a written notice
of any material changes and Grantee has waived in writing this Article 7(c).

               8.     The Closing.

                      (a) Any closing hereunder shall take place on the date
specified by the Grantee in its Stock Exercise Notice, as the case may be, at
10:00 A.M., local time, at the offices of the Company, 5861 Edison Place,
Carlsbad, California, or, if the

<PAGE>   5

conditions set forth in Section 7(a), (b), or (c) have not then been satisfied,
on the second business day following the satisfaction of such conditions, or at
such other time and place as the parties hereto may agree (the "Closing Date").
On the Closing Date or as soon thereafter as practicable, the Grantor will
deliver to the Grantee a certificate or certificates, representing the Shares in
the denominations designated by the Grantee in its Stock Exercise Notice and the
Grantee will acquire such Shares from the Grantor in the manner set forth in
Section 2. If any payment is required to be made by Grantee to the Grantor
pursuant to this Agreement, it shall be made by wire transfer of federal funds
to a bank designated by the Grantor.

                      (b) Grantee agrees not to transfer or otherwise dispose of
the Option or the Option Shares, or any interest therein, except in compliance
with the Securities Act and any applicable state securities law. Grantee further
agrees that the certificates representing the Option Shares shall bear an
appropriate legend relating to the fact that such Shares have not been
registered under the Securities Act.

               9. Listing of Shares; Filings; Governmental Consents. If shares
of the Company's Common Stock are registered or listed on any national
securities exchange or system during the term of this Agreement, subject to
applicable law and the rules and regulations of such national securities
exchange or system, after the Option becomes exercisable hereunder, Grantor will
promptly file an application to list the Option Shares on such exchange or
system. Additionally, Grantor will use its reasonable best efforts to obtain
approval of such listing and to effect all necessary filings; provided, however,
that if the Grantor is unable to effect such listing on the exchange or system
by the Closing Date, Grantor will nevertheless be obligated to deliver the
Option Shares on the Closing Date and to continue its efforts to obtain such
listing.

               10. Representations and Warranties of the Company

        The Company represents and warrants to Grantee as of the date hereof as
follows:

                      (a) Authorization of Agreements, etc. The execution and
delivery by the Company of this Agreement, the performance by the Company of its
obligations hereunder, and the issuance, sale and delivery of the Option have
been duly authorized, and the Option Shares, when issued and delivered, will be
duly authorized by all requisite corporate action and will not result in any
violation of, be in conflict with, or constitute a default under, with or
without the passage of time or the giving of notice: (a) any provision of the
Company's Articles of Incorporation, as amended, or Bylaws; (b) any provision of
any judgment, decree or order to which the Company is a party or by which it is
bound; (c) any material contract or agreement to which the Company is a party or
by which it is bound; or (d) any statute, rule or governmental regulation
applicable to the Company, except where such violation, conflict, or default
would not have a Company Material Adverse Effect.

                      (b) Valid Issuance of Common Stock. The Option Shares have
been duly authorized and reserved and, when issued, sold and delivered in
accordance with this Agreement for the consideration expressed herein will be

<PAGE>   6

validly issued, fully paid and nonassessable with no personal liability
attaching to the ownership thereof and will be free and clear of all liens,
charges and encumbrances of any nature whatsoever except for restrictions under
applicable Federal and state securities laws.

                      (c) Validity. This Agreement has been duly executed and
delivered by the Company and constitutes the legal, valid and binding obligation
of the Company, enforceable in accordance with its terms except (i) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws
of general application affecting enforcement of creditors' rights generally,
(ii) as limited by laws relating to the availability of specific performance,
injunctive relief, or other equitable remedies, and (iii) to the extent the
indemnification provisions contained in this Agreement may be limited by
applicable Federal or state securities laws.

                      (d) Capitalization. As of the date hereof, the authorized
capital stock of the Company consists of 50 million shares of Common Stock, no
par value, and 2 million shares of preferred stock, no par value, of which
12,953,385 shares of Common Stock are outstanding, no shares of preferred stock
are outstanding, and the only warrants, options or convertible securities
relating to the issuance by the Company of additional shares of its Common Stock
have been previously disclosed to Grantee. All of the issued and outstanding
shares of the Company's Common Stock are duly and validly issued and outstanding
and are fully paid and nonassessable.

                      (e) Organization, Good Standing and Qualification. Each of
the Company and its Subsidiaries is a corporation or limited liability company
duly organized, validly existing and in good standing under the laws of its
respective jurisdiction of organization. Each of the Company and each of its
Subsidiaries have all requisite corporate or limited liability company power and
authority to own and operate its respective properties and assets and to carry
on its business as presently conducted. Each of the Company and each of its
Subsidiaries is qualified to do business and is in good standing as a foreign
corporation or limited liability company in each jurisdiction where the
ownership or operation of its properties or conduct of its business requires
such qualification, except where the failure to be so qualified or in such good
standing, when taken together with all other such failures, is not reasonably
likely to have a Company Material Adverse Effect (as defined below) or impair
the ability of the Company, or any of its Subsidiaries, following consummation
of the Sale, to conduct any material business or operations in any jurisdiction
where they are now being conducted. All of the outstanding equity interests in
each such Subsidiary have been validly issued and are fully paid and
non-assessable and owned by the Company free and clear of all pledges, claims,
liens, charges, encumbrances and security interests of any kind or nature
whatsoever. The Company has made available to Grantee a complete and correct
copy of the Company's Articles of Incorporation and Bylaws (or similar
documents), each as amended to date. The Company's Articles of Incorporation and
Bylaws so made available are in full force and effect.

<PAGE>   7

                      (f) Governmental Filings. Other than any filings and/or
notices required pursuant to the HSR Act, federal securities laws and state
securities or "blue sky" laws, no notices or other filings are required to be
made by the Company with, nor are any consents, registrations, approvals,
permits or authorizations required to be obtained by the Company from, any
governmental or regulatory authority, agency, commission, body or other
governmental entity ("Governmental Entity"), in connection with the execution
and delivery of this Agreement by the Company and the consummation by the
Company of the Sale and the other transactions contemplated hereby, except those
that the failure to make or obtain are not, individually or in the aggregate,
reasonably likely to have a Company Material Adverse Effect or prevent,
materially delay or materially impair the ability of the Company to consummate
the transactions contemplated by this Agreement.

                      (g) Company Reports; Financial Statements. The Company
and, to the extent applicable, each of its Subsidiaries has made all filings
required to be made by it with the Commission since at least January 1, 1999
(collectively, the "Company Reports"). As of their respective dates, the Company
Reports complied in all material respects with the requirements of applicable
statutes and regulations (except for certain late filings) and did not, and any
Company Reports filed with the Commission prior to the Sale will not, contain
any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements made therein,
in light of the circumstances in which they were made, not misleading. Each of
the balance sheets included in or incorporated by reference into the Company
Reports (including the related notes and schedules) presents fairly, or will
present fairly, the financial position of the Company and its Subsidiaries as of
its date and each of the statements of income and of changes in financial
position included in or incorporated by reference into the Company Reports
(including any related notes and schedules) presents fairly, or will present
fairly, the results of operations, retained earnings and changes in financial
position, as the case may be, of the Company and its Subsidiaries for the
periods set forth therein (except as otherwise noted therein and subject, in the
case of unaudited statements, to notes and normal year-end audit adjustments
that will not be material in amount or effect), in each case in accordance with
generally accepted accounting principles ("GAAP") consistently applied during
the periods involved, except, in the case of unaudited financial statements, as
permitted by Commission Form 10-Q, and except as may be noted therein. The
Company has not, on or prior to the date hereof, filed any other definitive
reports or statements with the Commission since July 14, 2000.

                      (h) Litigation and Liabilities. Except for matters which
are disclosed in the Company Reports or those matters which are not,
individually or in the aggregate, reasonably likely to have a Company Material
Adverse Effect or prevent or materially delay or materially impair the ability
of the Company to consummate the transactions contemplated by this Agreement,
there are no (i) civil, criminal, administrative or regulatory actions, suits,
claims, hearings, investigations or proceedings pending or, to the knowledge of
the Company's officers and directors, threatened against the Company or any of
its Subsidiaries or (ii) material obligations or

<PAGE>   8

liabilities of the Company, whether or not accrued, contingent or otherwise and
whether or not required to be disclosed in the Company Reports.

                      (i) Compliance. Other than those matters which are
disclosed in the Company Reports, the Company is not in material default or
violation of, (a) its Articles of Incorporation or Bylaws, (b) any law,
ordinance, rule, regulation, order, judgment, decree, arbitration award, license
or permit of any Governmental Entity (collectively, "Laws") applicable to the
Company or by which its properties are bound, or (c) any material contract to
which the Company or any of its Subsidiaries is a party or by which the Company
or any of its Subsidiaries, or its or any of their respective properties, is
bound or affected, except for any such material defaults or violations that,
individually or in the aggregate, will not have a Company Material Adverse
Effect, or prevent or materially delay the transactions contemplated by this
Agreement. No material change is required in the Company's processes, properties
or procedures in order to comply in all material respects with any Laws, and the
Company has not received any notice of any material noncompliance with any such
Laws that has not been cured.

                      (j) Brokers and Finders. Neither the Company nor any of
its Subsidiaries, officers, directors or employees has employed any broker or
finder or incurred any liability for any brokerage fees, commissions or finders'
fees in connection with the Option or the Option Shares or the other
transactions contemplated by this Agreement.

                      (k) Certain Agreements. Neither the Company nor its
Subsidiaries has violated any provision of, or committed or failed to perform
any act which, with or without notice, lapse of time, or both, is reasonably
likely to constitute a default under the provisions of, any material contract of
the Company or such Subsidiary, and neither the Company nor any of its
Subsidiaries has received notice that any party to any such contract intends to
cancel, terminate or otherwise modify the terms of such contract, except in each
case, as is not reasonably likely to have, individually or in the aggregate, a
Company Material Adverse Effect.

                      (l) No Required Vote of Company Stockholders. This
Agreement and the transactions contemplated hereby must be approved by a
majority of the Company's outstanding Common Stock which are entitled to vote in
this matter, and the requisite approval has been obtained.

                      (m) Licenses and Permits. The Company and each Subsidiary
has obtained all material licenses, registrations, permits, approvals and other
governmental authorizations required to conduct its business as described in the
Company Reports. Such licenses are in full force and effect and neither the
Company nor any Subsidiary has received notice of proceedings relating to the
revocation or modification of any such license, permit, approval and other
governmental authorization.

               11.    Representations and Warranties of Purchaser

<PAGE>   9

               Purchaser represents and warrants to the Company as of the date
hereof as follows:

                      (a) Authorization. The execution and delivery by Grantee
of this Agreement and the performance by Grantee of its obligations hereunder
have been duly authorized.

                      (b) Validity. This Agreement has been duly executed and
delivered by Grantee and constitutes the legal, valid and binding obligation of
Grantee, enforceable in accordance with its terms except: (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of
general application affecting enforcement of creditors' rights generally; (ii)
as limited by laws relating to the availability of specific performance,
injunctive relief, or other equitable remedies; and (iii) to the extent the
indemnification provisions contained in this Agreement may be limited by
applicable Federal or state securities laws.

                      (c) Investment Representations. Grantee (i) is an
"accredited investor" within the meaning of Rule 501 of Regulation D under the
Securities Act of 1933, as amended (the "Securities Act") and was not organized
for the specific purpose of acquiring the Option Shares; (ii) has sufficient
knowledge and experience in investing in companies similar to the Company in
terms of the Company's stage of development so as to be able to evaluate the
risks and merits of its investment in the Company and it is able financially to
bear the risks thereof; and (iii) presently intends that the Option Shares that
may be acquired hereunder will be acquired for Grantee's own account for the
purpose of investment and not with a present view to or for sale in connection
with any distribution thereof.

                      (d) Grantee acknowledges that: (i) the Option Shares will
not be registered under the Securities Act by reason of their issuance in a
transaction exempt from the registration requirements of the Securities Act
pursuant to Section 4(2) thereof or Rule 505 or 506 promulgated under the
Securities Act; (ii) the Option Shares must be held indefinitely unless a
subsequent disposition thereof is registered under the Securities Act or is
exempt from such registration; (iii) the Option Shares will bear a legend to
such effect; and the Company will make a notation on its transfer books to such
effect; and (iv) the Company has made available to Grantee all documents and
information that the Grantee has requested relating to an investment in the
Company.

               12.    Piggyback Registration.

                      (a) At any time and from time to time after the date of
this Agreement, so long as DuPont then holds Registrable Shares, whenever the
Company proposes to file a Registration Statement, the Company will prior to
making the initial filing give written notice to DuPont of its intention to do
so and, upon the written request of DuPont given within twenty (20) days after
the Company provides such notice, the Company shall use its best efforts to
cause all Registrable Shares of DuPont which the Company has been requested by
DuPont to register, to be registered under the Securities

<PAGE>   10

Act to the extent necessary to permit their sale or other disposition in
accordance with the intended methods of distribution specified in the request of
DuPont; provided that the Company shall have the right to postpone or withdraw
any registration effected pursuant to this Section 12 without obligation to
DuPont.

                      (b) In connection with any registration under this Section
12 involving an underwritten offering of the Company's securities, the Company
shall not be required to include any Registrable Shares of DuPont in such
underwriting unless DuPont accepts the terms of the underwriting as agreed upon
between the Company and the underwriters selected by it, and then only in such
quantity as will not, in the reasonable discretion of the underwriters,
jeopardize the success of the offering by the Company. If in the reasonable
discretion of the managing underwriter or underwriters the registration of all,
or part of, the Registrable Shares which DuPont has requested to be included
would adversely affect such public offering, then the Company shall be required
to include in the underwriting only that number of Registrable Shares, if any,
which the managing underwriter or underwriters believe may be sold without
causing such adverse effect. If the number of Registrable Shares to be included
in the underwriting in accordance with the foregoing is less than the total
number of shares which DuPont has requested to be included, then DuPont and the
holders of registration rights previously or subsequently granted shall
participate in the underwriting on a pro rata basis upon the total number of
Registrable Shares which DuPont has requested to be included compared to the
total number of shares of the Company's capital stock held by the holders of
registration rights previously or subsequently granted which such holders have
requested to be included, whether or not such shares are the subject of separate
agreements with the Company concerning registration rights.

               13. Registration Procedures. When the Company is required by the
provisions of this Agreement to effect the registration of any of the
Registrable Shares under the Securities Act, the Company shall:

                      (a) file with the Commission a Registration Statement with
respect to such Registrable Shares and use its best efforts to cause that
Registration Statement to become and remain effective;

                      (b) as expeditiously as possible prepare and file with the
Commission any amendments and supplements to the Registration Statement and the
prospectus included in the Registration Statement as may be necessary to keep
the Registration Statement effective until the earlier to occur of such time as
all Registrable Shares included therein have been sold or the expiration of nine
months unless such Registration Statement is on form S-3 in which case the
expiration period shall be two years;

                      (c) as expeditiously as possible furnish to DuPont such
reasonable numbers of copies of the prospectus, including a preliminary

<PAGE>   11

prospectus and any amended or supplemental prospectus, in conformity with the
requirements of the Securities Act, and such other documents as DuPont may each
reasonably request in order to facilitate the public sale or other disposition
of DuPont's Registrable Shares; and

                      (d) as expeditiously as possible use its best efforts to
register or qualify the Registrable Shares covered by the Registration Statement
under the securities or Blue Sky laws of such states as DuPont shall reasonably
request, and do any and all other acts and things that may be necessary or
desirable to enable DuPont to consummate the public sale or other disposition of
the Registrable Shares owned by DuPont in such jurisdiction; provided, however,
that the Company shall not be required in connection with this Section 13 to
qualify as a foreign corporation in any jurisdiction or register or qualify the
securities in any state which as a condition to such registration or
qualification would impose material restrictions or other material conditions on
the Company or any of its officers, directors or shareholders (including with
respect to any shares held by such persons or entities) unless such restrictions
or other conditions are approved by the party adversely affected.

               If the Company advises DuPont that any preliminary or final
prospectus is no longer in compliance with the requirements of the Securities
Act, or that at such time it is otherwise a violation of any applicable
securities laws to offer or sell securities pursuant to a preliminary or final
prospectus, DuPont shall immediately cease offering or selling the Registrable
Securities and, if requested, return the old prospectus to the Company. DuPont
may recommence offers and sales of Registrable Securities upon receipt from the
Company of an amended prospectus, if applicable, or receipt of ratification from
the Company that the offer and sale of Registrable Securities may resume.

               14. Allocation of Expenses. The Company will pay all Registration
Expenses of all registrations under this Agreement. The term "Registration
Expenses" shall mean all expenses incurred by the Company in complying with this
Agreement, including, without limitation, all registration and filing fees,
exchange listing fees, printing expenses, fees and disbursements of counsel for
the Company, state Blue Sky fees and expenses, and the expense of any special
audits incident to or required by any such registration, but excluding
underwriting discounts and selling commissions attributable to the Registrable
Shares and the fees and expenses of DuPont's own counsel and accountants, which
shall be borne by DuPont.

               15. Information by DuPont. DuPont shall promptly furnish to the
Company such information regarding DuPont and the distribution proposed by
DuPont as the Company may request in writing and as shall be required in
connection with any registration, qualification or compliance referred to in
this Agreement.

               16. "Lock-up" Agreement. If requested by an underwriter in
connection with an underwritten offering of Common Stock or other securities of
the Company, DuPont shall agree not to sell or otherwise transfer or dispose of
any Registrable Shares or

<PAGE>   12

other securities of the Company held by it for a specified and reasonable period
of time before and/or after the effective date of a Registration Statement,
provided that the same request shall have been made of other holders of the
Company's Common Stock or other securities (including affiliates of the Company)
and such other holders have complied with such request. Such agreement shall be
in writing in a form satisfactory to the Company and any such underwriter. The
Company may impose stop transfer instructions with respect to the Registrable
Shares or other securities subject to the foregoing restriction until the end of
the lock-up period.

               17.    Indemnification.

                      (a) By the Company. In the event of any registration of
any of the Registrable Shares under the Securities Act pursuant to this
Agreement, the Company will indemnify and hold harmless DuPont, its directors,
officers and underwriters against any losses, claims, damages or liabilities,
joint or several, to which DuPont may become subject under the Securities Act,
Exchange Act, state securities laws or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or
are based upon any untrue statement of any material fact contained in any
Registration Statement under which such Registrable Shares were registered under
the Securities Act, any preliminary prospectus or final prospectus contained in
the Registration Statement, or any amendment or supplement to such Registration
Statement, or arise out of or are based upon the omission to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading; and the Company will reimburse DuPont for any legal or any other
expenses reasonably incurred by DuPont in connection with investigating and
defending any such loss, claim, damage, liability or action; provided, however,
that the Company will not be liable in any such case to the extent that any such
loss, claim, damage, liability or expense arises out of or is based upon any
untrue statement or omission made in such Registration Statement, preliminary
prospectus or prospectus, or any such amendment or supplement, in reliance upon
and in conformity with information furnished to the Company by or on behalf of
DuPont, specifically for use in the preparation thereof, or as a result of the
failure of DuPont, or any agent of DuPont, to deliver any amendments and
supplements to any Registration Statement and the prospectus included in any
such Registration Statement (provided such amended or supplemental prospectus
has been delivered to DuPont or its agent).

                      (b) By DuPont. In the event of any registration of any of
the Registrable Shares under the Securities Act pursuant to this Agreement,
DuPont will indemnify and hold harmless the Company, each of its directors and
officers and each underwriter (if any) and each person, if any, who controls the
Company or any such underwriter within the meaning of the Securities Act or the
Exchange Act, against any losses, claims, damages or liabilities, joint or
several, to which the Company, such directors and officers, underwriter or
controlling person may become subject under the Securities Act, Exchange Act,
state securities laws or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or

<PAGE>   13

are based upon any untrue statement of a material fact contained in any
Registration Statement under which such Registrable Shares were registered under
the Securities Act, any preliminary prospectus or final prospectus contained in
the Registration Statement, or any amendment or supplement to the Registration
Statement, or arise out of or are based upon any omission or alleged omission to
state a material fact required to be stated therein or necessary to make the
statements therein not misleading and DuPont will reimburse the Company, each of
its directors and officers, each underwriter and each controlling person,
severally and not jointly, for any legal or other expenses reasonably incurred
by the Company, each director and officer, each underwriter and each controlling
person in connection with investigating and defending any such loss, claim,
damage, liability or action, only if the statement or omission was made in
reliance upon and in conformity with written information furnished to the
Company by or on behalf of DuPont, specifically for use in connection with the
preparation of such Registration Statement, prospectus, amendment or supplement.

                      (c) Claims. Each party entitled to indemnification under
this Section 17 (the "Indemnified Party") shall give notice to the party
required to provide indemnification (the "Indemnifying Party") promptly after
such Indemnified Party has actual knowledge of any claim as to which indemnity
may be sought, and shall permit the Indemnifying Party to assume the defense of
any such claim or any litigation resulting therefrom; provided, that counsel for
the Indemnifying Party, who shall conduct the defense of such claim or
litigation, shall be approved by the Indemnified Party (whose approval shall not
be unreasonably withheld); and, provided, further, that the failure of any
Indemnified Party to give notice as provided herein shall not relieve the
Indemnifying Party of its obligations under this Section 17. The Indemnified
Party may participate in such defense at such party's expense. No Indemnifying
Party, in the defense of any such claim or litigation, except with the consent
of the Indemnified Party, shall consent to entry of any judgment or enter into
any settlement, which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from
all liability in respect of such claim or litigation.

               18. Mergers, Etc. Prior to the exercise or Termination of the
Option, the Company shall not, directly or indirectly, enter into any merger,
consolidation or reorganization in which the Company shall not be the surviving
corporation unless the proposed surviving corporation shall, prior to such
merger, consolidation or reorganization, agree in writing to assume the
obligations of the Company under this Agreement, and for that purpose references
hereunder to "Registrable Shares" shall be deemed to be references to the
securities which DuPont would be entitled to receive in exchange for Registrable
Shares under any such merger, consolidation or reorganization; provided,
however, that the provisions of this Section 18 shall not apply in the event of
any merger, consolidation or reorganization in which the Company is not the
surviving corporation if all holders of Common Stock of the Company are entitled
to receive in exchange for their Registrable Shares consideration consisting
solely of (i) cash, (ii) securities of the acquiring corporation which may be
immediately sold to the public without registration under the Securities Act, or
(iii) securities of the acquiring corporation

<PAGE>   14

which the acquiring corporation has agreed to register within 90 days of
completion of the transaction for resale to the public pursuant to the
Securities Act.

               19. Modification or Amendment. This Agreement may be modified or
amended only by written agreement executed and delivered by duly authorized
officers of the respective parties.

               20. Counterparts. This Agreement may be executed in any number of
counterparts, each such counterpart being deemed to be an original instrument,
and all such counterparts shall together constitute the same agreement.

               21. Governing Law and Waiver of Jury Trial.

                      (a) This Agreement shall be deemed to be made in and in
all respects shall be interpreted, construed and governed by and in accordance
with the laws of the State of Delaware without regard to the conflict of law
principles thereof.

                      (b) Each Party acknowledges and agrees that any
controversy which may arise under this Agreement is likely to involve
complicated and difficult issues, and therefore each such Party hereby
irrevocably and unconditionally waives any right such Party may have to a trial
by jury in respect of any litigation directly or indirectly arising out of or
relating to this Agreement, the other documents referred to in this Agreement,
or the transactions contemplated hereby or thereby. Each Party certifies and
acknowledges that (i) no representative, agent or attorney of any other Party
has represented, expressly or otherwise, that such other Party would not, in the
event of litigation, seek to enforce the foregoing waiver, (ii) each such party
understands and has considered the implications of this waiver, (iii) each such
party makes this waiver voluntary and (iv) each such Party has been induced to
enter into this Agreement by, among other things, the mutual waivers and
certifications in this section.

<PAGE>   15

               22. Binding Arbitration. In the event of a dispute between the
parties arising out of or relating to this Agreement, either party may upon
notice to the other submit all disputes, claims, questions or differences to be
finally settled by arbitration administered by the American Arbitration
Association in accordance with the provisions of its Commercial Arbitration
Rules and judgment on the award rendered by the arbitrator(s) may be entered in
any court having jurisdiction thereof. Each party shall bear its own costs and
expenses and an equal share of the arbitrator(s) and administrative fees of
arbitration. The place of arbitration shall be Chicago, Illinois. The
arbitrator(s) will have no authority to award punitive or other damages not
measured by the prevailing party's actual damages, except as may be required by
statute.

               23. Notices. Any notice, request, instruction or other document
to be given hereunder by any party to the others shall be in writing and
delivered personally or sent by registered or certified mail, postage prepaid,
or by facsimile:

               if to the Grantee:

                      Global Segment Manager - Gloves
                      DuPont Lycra(R)
                      Barley Mill Plaza 25/2210
                      Wilmington, DE  19880-0025
                      Fax: (302) 892-0788

               with copies to:

                      Mr. John Dickey
                      E. I. du Pont de Nemours and Company
                      Barley Mill Plaza 25-2218
                      Lancaster Pike & Route 141
                      Wilmington, DE  19805
                      Fax: (302) 892-0788

               if to the Grantor:

                      Mr. Kevin Mulvihill
                      President and Chief Executive Officer
                      Wilshire Technologies
                      5861 Edison Place
                      Carlsbad, CA  92008
                      Fax:  (760) 929-0683

               with copies to:

<PAGE>   16

                      Richard L. Seidenwurm
                      Solomon Ward Seidenwurm & Smith, LLP
                      401 B Street, Suite 1200
                      San Diego, California 92101
                      Fax: (619) 231-4755

or to such other persons or addresses as may be designated in writing by the
party to receive such notice as provided above.

               24. Entire Agreement. This Agreement (including any exhibits and
schedules hereto) constitutes the entire agreement, and supersede all other
prior agreements, understandings, representations and warranties both written
and oral, among the parties, with respect to the subject matter hereof.

               25. No Third Party Beneficiaries. This Agreement is not intended
to confer upon any person or entity other than the parties hereto any right or
remedies hereunder.

               26 Severability. The provisions of this Agreement shall be deemed
severable and the invalidity or unenforceability of any provision shall not
affect the validity or enforceability of the other provisions hereof. If any
provision of this Agreement, or the application thereof to any person or entity
or any circumstance, is invalid or unenforceable, (a) a suitable and equitable
provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (b) the remainder of this Agreement and the application of such
provision to other persons or entities or circumstances shall not be affected by
such invalidity or unenforceability, nor shall such invalidity or
unenforceability affect the validity or enforceability of such provision, or the
application thereof, in any other jurisdiction.

               27. Specific Performance. The parties hereto each acknowledge
that, in view of the uniqueness of the subject matter hereof, the parties hereto
would not have an adequate remedy at law for money damages if this Agreement
were not performed in accordance with its terms, and therefore agree that the
parties hereto shall be entitled to specific enforcement of the terms hereof in
addition to any other remedy to which the parties hereto may be entitled at law
or in equity.

               28. Assignment. This Agreement is not assignable by either party;
provided, however, that DuPont may assign its rights and obligations under this
Agreement to any of its direct or indirect Subsidiaries. Any purported
assignment made in contravention of this Agreement shall be null and void.

               29. Captions. The Section captions herein are for convenience of
reference only and do not constitute part of this Agreement and shall not be
deemed to limit or otherwise affect any of the provisions hereof.

<PAGE>   17

               30. Termination.

                      (a) The right to exercise the Option granted pursuant to
this Agreement shall terminate on December 31, 2002 (the "Termination Date");
provided, however, that, if the Option cannot be exercised or the Option Shares
cannot be delivered to the Grantee upon such exercise because one or more of the
conditions set forth in Section 7 (a), (b) or (c) hereof have not yet been
satisfied, the Termination Date shall be extended until fifteen days after such
impediment to exercise or delivery has been removed. Following Termination
Grantee shall provide Grantor an acknowledgement that the Option has been
terminated.

                      (b) All representations and warranties contained in this
Agreement shall survive delivery of and payment for the Shares.

               IN WITNESS WHEREOF, this Agreement has been duly executed and
delivered by duly authorized officers of the parties hereto as of the date
hereof.

                                    WILSHIRE TECHNOLOGIES, INC.

                                    By: /s/ Kevin Mulvihill
                                        ----------------------------------------
                                    Name: Kevin Mulvihill
                                          --------------------------------------
                                    Title: President and CEO
                                           -------------------------------------

                                    E. I. du Pont de Nemours and Company

                                    By:  /s/  William Ghitis
                                         ---------------------------------------
                                    Name: William Ghitis
                                          --------------------------------------
                                    Title: Vice President, Global NBD
                                           -------------------------------------<PAGE>   1
                                                                  EXHIBIT 10.183

                           TRADEMARK LICENSE AGREEMENT

               THIS AGREEMENT made this 18th day of September, 2000 ("Effective
Date") between E. I. DUPONT DE NEMOURS AND COMPANY, a corporation of the State
of Delaware, U.S.A., with its principal place of business at 1007 Market Street,
Wilmington, Delaware 19898, U.S.A. ("DUPONT"), and WILSHIRE TECHNOLOGIES, INC.,
a corporation organized and existing under the laws of California, with its head
office at Carlsbad, California ("LICENSEE")

                                   WITNESSETH;

               WHEREAS, DUPONT is the owner of the registered Trademark
("Trademark") set forth in Exhibit A;

               WHEREAS, LICENSEE desires a license under the Trademark, and
DUPONT is willing to grant the same upon the terms and conditions hereinafter
recited;

               NOW, THEREFORE, in consideration of the mutual rights and
obligations of the parties herein;

               DUPONT and LICENSEE agree as follows:

1.  GRANTS: DUPONT hereby grants to LICENSEE a nontransferable, nonassignable,
    revocable, nonexclusive right, without the right to sublicense, to use the
    Trademark, solely and only in the Territory, Field of Use, and Distribution
    Channels set forth in Exhibit A, on and in connection with the display,
    advertising, promotion, labeling, sale, marketing, and distribution of
    Products set forth in Exhibit A.

    a)  Limited License: Nothing in this Agreement shall be construed to grant
        LICENSEE any rights or license to any trademark, trade name,
        certification mark, service mark, domain name, product name, logo,
        patent, technical information, or copyright of DUPONT other than as
        specified herein. All rights not specifically granted to LICENSEE are
        reserved to DUPONT.

    b)  USE: DUPONT reserves the right as owner of the Trademark to specify all
        aspects of use of the Trademark, including but not limited to, the
        manner, place, type, form, layout, design, channels of trade, channels
        of distribution, and media of or for such use, on or in connection with,
        all displays, advertising, labels, Products literature, Internet sites,
        sales promotion materials, and all other forms of use of the Trademark.
        All use of the licensed Trademark shall inure to the benefit of DUPONT.
        LICENSEE shall comply with any specific trademark use rules as

                                       1
<PAGE>   2

        may be referenced in any of the Exhibits, or provided to LICENSEE, which
        may be amended or revised by DUPONT from time to time, upon written
        notice.

    c)  ACKNOWLEDGMENT: LICENSEE hereby acknowledges the validity of DUPONT's
        Trademark and DUPONT's exclusive right, title and interest in and to the
        Trademark. LICENSEE shall not, during the term of this Agreement, or
        thereafter: 1) do or permit to be done any act or thing which
        prejudices, infringes or impairs the rights of DUPONT with respect to
        the Trademark; 2) except for the limited license granted hereunder, will
        never represent that it has any right, title, or interest in or to the
        Trademark or in any registration for them; 3) shall not use, register or
        attempt to register any Trademark, trade names, logos, domain names,
        metatags, or electronic mail (e-mail) addresses, that are identical to,
        or confusingly similar to the Trademark or any other Trademark, trade
        names or domain names of DUPONT or any of its subsidiaries or affiliated
        companies; 4) shall not do anything or produce any goods in connection
        with the Trademark that damages or reflects adversely upon DUPONT, its
        subsidiaries or affiliated companies or any of their trademarks, trade
        names or domain names; 5) upon objection by DUPONT acting on good cause,
        shall forthwith desist from any use or action in relation to or in
        connection with the Trademark or this Agreement; and 6) when requested
        by DUPONT, shall employ identifying symbols and/or words in connection
        with its use of the Trademark. LICENSEE shall cooperate with DUPONT in
        taking all appropriate measures for the protection of the Trademark, and
        shall faithfully observe and execute the requirements, procedures, and
        directions of DUPONT with respect to the use and protection of the
        Trademark.

    d)  GOODWILL: LICENSEE recognizes the value of the reputation and goodwill
        associated with the Trademark, acknowledges that the Trademark and any
        marks confusingly similar to the Trademark have acquired secondary
        meaning, and that all related rights and goodwill belong exclusively to
        DUPONT.

    e)  ART WORK: All art and design or lay-out work that contains, is derived
        from or used with the Trademark, shall be solely owned by DUPONT.
        LICENSEE shall not obtain, attempt to obtain or claim any copyright or
        trademark rights therein, and upon request, LICENSEE shall assign same
        to DUPONT.

    f)  NOTIFICATION OF INFRINGEMENT: LICENSEE shall notify DUPONT in writing of
        any manufacture, distribution, sale or advertisement of any product or
        service that may constitute an infringement upon DUPONT's rights or
        LICENSEE's authorized use of the Trademark. LICENSEE shall not commence,
        prosecute or institute any action or proceeding against any person,
        firm, or entity alleging infringement, imitation, or unauthorized use of
        the Trademark.

    g)  INFRINGEMENT ACTION: DUPONT shall have the sole right to determine the
        appropriate action to be taken against any

                                       2
<PAGE>   3

        infringement, imitation, or unauthorized use of the Trademark including
        having the sole discretion to settle any claims or any controversy
        arising out of any such claims. LICENSEE shall provide DUPONT with such
        reasonable assistance as DUPONT may require in obtaining any protection
        of DUPONT's rights to the Trademark at no expense to DUPONT. LICENSEE
        shall not have any rights or claim against DUPONT for damages or
        otherwise arising from any determination by DUPONT to act or not to act
        with respect to any alleged infringement, imitation or unauthorized use
        by others, and any such determination by DUPONT shall not affect the
        validity or enforceability of this Agreement. Any and all damages and
        settlements recovered arising from any action or proceeding shall belong
        solely and exclusively to DUPONT.

    h)  ASSIGNMENT TO DUPONT: Upon request, LICENSEE shall transfer to DUPONT
        any rights which accrue to LICENSEE arising from its use of the
        Trademark or this Agreement.

2.      ROYALTY: Any applicable royalties hereunder are set forth in Exhibit A..

3.      QUALITY STANDARDS, INSPECTION, AND TESTING: So that the value of the
        goodwill and reputation associated with the Trademark will not be
        diminished, LICENSEE shall have an obligation to ensure that all
        Products on which the Trademark is used shall be of at least the same
        uniform high quality: a) as manufactured by LICENSEE immediately prior
        to the effective date of this Agreement; b) as may be approved by DUPONT
        hereunder; or 3) as specified in quality standards provided by DUPONT
        hereunder, as the case may be. To monitor for LICENSEE's adherence to
        such obligation, DUPONT shall have the right, from time to time through
        duly authorized representatives, to inspect and test such Products.
        Licensed Products not meeting the quality or other requirements set
        forth in this Agreement shall not be sold or in any way promoted in
        connection with the Trademark, and all references to the Trademark on
        labels, product literature, promotional material, etc., shall be removed
        at LICENSEE'S expense. LICENSEE shall be responsible for ensuring that
        any manufacturer of Products, for or on behalf of LICENSEE, shall meet
        the quality and other requirements of this Agreement.

4.      LICENSING NOTICE: LICENSEE shall include a notice on all labeling,
        advertising, Products literature, Internet sites, and sales promotional
        material that the Trademark is licensed from DUPONT. The notice shall be
        as follows or as otherwise specified by DUPONT:

           "LYCRA(R) is a registered Trademark of
           E. I. du Pont de Nemours Company and is used under license to
           Wilshire Technologies, Inc."

5.      TERM AND TERMINATION: This Agreement shall become effective upon the
        Effective Date and shall continue in full force and effect until:

                                       3
<PAGE>   4

    (a) the termination of Article IV of the Product Development, Purchase and
        License Agreement between DuPont and Licensee effective September 18,
        2000 or

    (b) terminated by either party upon thirty (30) days' prior written notice.
        Such termination if by DuPont must be with cause. In the event of a
        proper termination neither party shall be liable to the other for any
        loss, expense, liability, termination compensation or payments of any
        kind, including but not limited to, any investment, promotion or selling
        expense. Upon proper termination of this Agreement, LICENSEE shall
        immediately discontinue all use of the Trademark.

6.      CHOICE OF LAW: This Agreement is acknowledged to have been made in and
        shall be construed in accordance with the laws of the State of Delaware,
        U.S.A.

7.      NO CONSEQUENTIAL DAMAGES, ETC.: In no event shall either party be liable
        for ANY special, indirect, incidental, punitive, consequential, or any
        similar damages whether or not caused by or resulting from the
        negligence of such party even if such party has been advised of the
        possibility of such damages, in RELATION TO, ARISING OUT OF OR IN
        CONNECTION WITH THIS AGREEMENT OR THE TRADEMARK.

8.      SUPPLEMENTAL PROVISIONS: If any supplemental provisions are made a part
        of this Agreement, they are set forth in Exhibit B.

9.      MANNER OF EXECUTION OF THE AGREEMENT: This Agreement may be executed by
        (1) both parties signing the Agreement, or (2) either party signing the
        Agreement, faxing such signed Agreement to the other party, the other
        party signing the faxed, previously signed Agreement, and faxing or
        otherwise providing the fully executed Agreement to the other party.
        Both of such executed versions (1) and (2) shall be considered to have
        been fully executed by the parties and shall be valid and enforceable.

10.     ADMINISTRATION: This Agreement may be administered by a subsidiary or
        affiliate of DUPONT.

11.     SURVIVAL: Notwithstanding termination, expiration or cancellation of
        this Agreement (collectively referred to hereinafter in this item 11 as
        "Termination"), items 1(a)-1(h) and 6-12 shall survive Termination of
        this Agreement. In addition, notwithstanding Termination of this
        Agreement, all provisions of this Agreement, to the extent necessary to
        interpret the rights and obligations of the parties prior to such
        termination, and/or enforce same, shall survive termination.

12.     INDEMNITY: LICENSEE hereby indemnifies, defends, and holds DUPONT
        harmless from and against any and all claims, suits, obligations, causes
        of action, liabilities, costs, and damages (including without limitation
        reasonable attorney's fees and court costs, injuries to persons and
        damages to property, products liability

                                       4
<PAGE>   5

        claims, and claims for environmental harms) based upon, arising out of,
        or directly or indirectly related to, the operations or business
        conducted by LICENSEE under this or related to this Agreement (including
        without limitation the design, testing, manufacture, sale, distribution,
        marketing, use, display, advertising, or promotion of Products sold or
        promoted in connection with any of the Trademark); provided, however,
        that such indemnity shall not apply to the extent of problems solely
        related to DUPONT's supply of defective ingredients for Products. Said
        indemnity shall further extend to the LICENSEE's performance or
        nonperformance under this Agreement, including any default on the part
        of the LICENSEE, whether or not any such violation or failure to comply
        has been disclosed to DUPONT. This indemnity and all representations and
        warranties made by the Parties herein or in any instrument or document
        furnished in connection herewith shall survive termination of the
        Agreement.

13.     LEGAL OBLIGATIONS: The parties' legal obligations under this Agreement
        are to be determined from the precise and literal language of this
        Agreement and not from the imposition of laws attempting to impose
        additional duties or fiduciary obligations or any other similar
        obligation that were not the express basis of the bargain at the time
        this Agreement was made.

14.     COUNSEL: The parties are sophisticated businesses with legal counsel to
        review the terms of this Agreement, and the parties represent that they
        have fully read this Agreement and understand and accept its terms.

15.     COMPLETE CONTRACT: This Agreement contains the entire contract and
        understanding between the parties with regard to Trademark. There are no
        representations or understandings, oral or written, express or implied,
        that are not merged herein. This Agreement may not be modified or
        terminated orally. Exhibit A and Exhibit B (if applicable) are
        incorporated herein by reference. No alleged modification, termination,
        or waiver shall be binding unless it is set out in writing and signed by
        the party against which it is sought to be enforced; and all prior
        agreements and/or understandings oral or written, express or implied,
        between the parties with respect to the subject matter hereof are hereby
        terminated.

                                       5
<PAGE>   6

IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate by
their duly authorized representatives as of the day and year first above
written.

E. I. DU PONT DE NEMOURS AND COMPANY

        By: /s/ William Ghitis
           ----------------------------------

        Printed Name: William Ghitis
                     ------------------------

        Title: Vice President, Global NBD
               ------------------------------

WILSHIRE TECHNOLOGIES, INC.

        By  /s/ Kevin Mulvihill
           ----------------------------------

        Printed Name: Kevin Mulvihill
                     ------------------------

        Title  President and CEO
               ------------------------------

                                       6
<PAGE>   7

                                    EXHIBIT A

"TRADEMARK" SHALL MEAN LYCRA.

"TERRITORY" SHALL MEAN WILSHIRE TERRITORY*

"FIELD OF USE" SHALL MEAN PRODUCT*

"DISTRIBUTION CHANNELS" SHALL MEAN ALL DIRECT AND INDIRECT SALES CHANNELS

1."PRODUCTS" SHALL MEAN GLOVES MANUFACTURED FROM POLYMER* SOURCED SOLELY FROM
DUPONT.

* TERMS AS DEFINED IN THE PRODUCT DEVELOPMENT, PURCHASE AND LICENSE AGREEMENT
BETWEEN THE PARTIES OF THE SAME DATE AS THIS AGREEMENT.

ROYALTY:

    This Agreement shall be royalty free.

                                       7
<PAGE>   8

                                    EXHIBIT B

                             SUPPLEMENTAL PROVISIONS

                           TRADEMARK LICENSE AGREEMENT

1.  PRODUCTS REQUIREMENTS: LICENSEE shall not use the Trademark in connection
    with the promotion or sale of Products unless:

    a)  the polyurethane used to make the Products is solely manufactured and
        sold by DUPONT or any of its affiliated companies and

    b)  LICENSEE has employed, and has required its suppliers to employ,
        manufacturing and Products specifications and quality control procedures
        sufficient to assure consistent high quality. LICENSEE certifies that
        the Products shall meet or exceed any and all applicable government or
        industry standards, regulations, guidelines, rules, laws, and the like
        as well as any additional quality control standards as may be agreed to
        in writing by DUPONT and LICENSEE.

    c)  LICENSEE shall maintain representative samples of all Products, labels,
        literature, advertisements, and other promotional materials using or
        incorporating the Trademark, and shall make such samples available to
        DUPONT upon request. In addition, LICENSEE shall maintain and employ
        procedures for documenting and recording customer complaints regarding
        the Products. Material customer complaints shall be reported to DUPONT
        immediately.

        If requested by DUPONT, LICENSEE shall provide to DUPONT for approval,
        prior to any use by LICENSEE, representative samples of all new or
        modified Products, as well as all new or modified promotional materials,
        advertisements, labels, and other materials displaying or bearing the
        Trademark, and use thereof shall not commence until approved by DUPONT.

2.  PROPER USE OF TRADEMARK: LICENSEE's trade name and/or logo and the Products
    name may be used in conjunction with the Trademark on labels, tags, ads, and
    promotional materials for Products. LICENSEE shall use the Trademark only in
    the manner provided in the Proper Usage Guidelines, attached hereto and made
    a part hereof. These Guidelines may be changed from time to time by DUPONT
    upon thirty (30) day' notice to LICENSEE.

3.  COMPLIANCE WITH LAWS: LICENSEE shall observe and comply with all laws,
    rules, and regulations applicable to the manufacturing, packaging, storing,
    handling, and sale of Products, and LICENSEE shall, at its own cost and
    expense, secure all necessary governmental permits and approvals necessary
    to manufacture, package and sell the Products. LICENSEE shall promptly
    report to DUPONT any governmental action of any kind, actual or threatened,
    concerning any of its Products.

4.  RESPONSIBILITIES OF DUPONT: DUPONT is a supplier of polyurethane polymer
    which is an ingredient in the manufacture of Products. DUPONT does not
    engage in the manufacture of Products, and shall not assume responsibility
    for any Products that are promoted or sold in connection with the Trademark
    or for claims by third parties arising out of the use of any Products
    promoted or sold in connection with the Trademark, except to the extent of
    DUPONT'S sole negligence in manufacturing the polyurethane supplied to
    LICENSEE. Polyurethane supplied by DUPONT shall meet DUPONT's release
    specifications of such materials in effect at the time of shipment.

                                       1
<PAGE>   9

5.  LICENSEE MANUFACTURE OF PRODUCTS: LICENSEE is responsible for the design and
    manufacture of Products. LICENSEE has chosen DUPONT's polyurethane because
    LICENSEE believes it is appropriate. LICENSEE has a staff properly trained
    in the requirements of Products and who are experienced and knowledgeable in
    the properties and processing of ppolyurethane. LICENSEE is an experienced
    manufacturer of Products and LICENSEE is responsible for assuring the
    quality and safety of Products. LICENSEE will provide its customers with any
    appropriate warnings necessary for the safe use of Products.

                                       2
<PAGE>   10

                     Proper usage of the LYCRA(R) Trademark

FOR CATALOGS, BROCHURES, IN-STORE SIGNAGE, INTERNET, ADVERTISING AND OTHER
PRINTED MATERIALS:

1.      Show registration status by using the "(R)" symbol each and every time
        the registered trademark appears. If there is no "(R)" on your keyboard,
        as in some electronic mail systems, use parenthesis "R" parenthesis (R).

Incorrect:                                   Correct:
LYCRA                                        LYCRA(R)
                                             LYCRA(R)

        In addition to using "(R)" or (R), a footnote must be used at least once
in each document, if possible.

Incorrect:                                   Correct:
(Trademark used without                      LYCRA(R) is a DuPont registered
appropriate footnote)                        trademark licensed to [LICENSEE]

2.      Never do the following:

        -  USE LYCRA(R) AS AN ADJECTIVE.
               Incorrect:           Correct:
               LYCRA(R) swimwear    swimwear with LYCRA(R)

        -  USE LYCRA(R) AS A POSSESSIVE.
               Incorrect:           Correct:
               LYCRA(R)'s comfort   the comfort of LYCRA(R)

        -  USE LYCRA(R) IN HYPHENATED FORM.
               Incorrect:           Correct:
               LYCRA(R)-containing garments       Garments containing LYCRA(R)

        Not all [generic] is LYCRA(R).
        LYCRA(R) is a DuPont registered trademark for its brand of [generic]

3.      Always make the trademark distinctive from surrounding type.

        -  Proper Usage:
               All Caps:      LYCRA(R)            Italics:   LYCRA(R)
               Bold:          LYCRA(R)            Quotes:    "LYCRA(R)"

For questions about the proper use of the LYCRA(R) trademark, licenses,
sub-brands and new research, or to report misuse, please contact your DuPont
marketing representative directly or via our toll-free number: 1-800-64-LYCRA(R)

LYCRA(R) is a registered trademark of the DuPont Company. Only DuPont makes
LYCRA(R).

                                                                    [LYCRA LOGO]

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]